| Daniel Chadwick, MD | |
|
901 Fm 1187 E, Crowley, TX 76036-4358 | |
| (817) 568-2023 | |
| (817) 568-2738 |
| Full Name | Daniel Chadwick |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 27 Years |
| Location | 901 Fm 1187 E, Crowley, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508828245 | NPI | - | NPPES |
| 1508828245 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | L5699 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Texas Health Huguley Hospital Fort Worth South | Burleson, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Huguley Medical Associates, Inc | 2668562471 | 38 |
News Archive
According to a study conducted at The University of Texas M. D. Anderson Cancer Center, more than twice as many women with early stage, HER-2 positive breast disease who received Herceptin as part of their pre-surgery chemotherapy had their tumors completely disappear compared to like patients who received only chemotherapy.
A team of University of Houston pharmaceutical researchers is reporting a newly recognized process of drug metabolism in the intestines - followed by recycling through the liver - that could have important implications for developing treatments for intestinal diseases and for taking multiple medications at the same time.
The Yale Global Health Leadership Institute announces a new partnership with Management Science for Health, as part of the United States Agency for International Development (USAID)-funded Leadership, Management and Governance Project.
New study from researchers in Finland and the United Kingdom reveals that tumors lacking a protein called BAP1 have an ineffective immune reaction against cancer, thus rendering immunotherapies ineffectual, particularly in uveal melanomas.
› Verified 2 days ago
| Entity Name | Huguley Medical Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629290929 PECOS PAC ID: 2668562471 Enrollment ID: O20071217000800 |
News Archive
According to a study conducted at The University of Texas M. D. Anderson Cancer Center, more than twice as many women with early stage, HER-2 positive breast disease who received Herceptin as part of their pre-surgery chemotherapy had their tumors completely disappear compared to like patients who received only chemotherapy.
A team of University of Houston pharmaceutical researchers is reporting a newly recognized process of drug metabolism in the intestines - followed by recycling through the liver - that could have important implications for developing treatments for intestinal diseases and for taking multiple medications at the same time.
The Yale Global Health Leadership Institute announces a new partnership with Management Science for Health, as part of the United States Agency for International Development (USAID)-funded Leadership, Management and Governance Project.
New study from researchers in Finland and the United Kingdom reveals that tumors lacking a protein called BAP1 have an ineffective immune reaction against cancer, thus rendering immunotherapies ineffectual, particularly in uveal melanomas.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Chadwick, MD 901 Fm 1187 E, Crowley, TX 76036-4358 Ph: (817) 568-2023 | Daniel Chadwick, MD 901 Fm 1187 E, Crowley, TX 76036-4358 Ph: (817) 568-2023 |
News Archive
According to a study conducted at The University of Texas M. D. Anderson Cancer Center, more than twice as many women with early stage, HER-2 positive breast disease who received Herceptin as part of their pre-surgery chemotherapy had their tumors completely disappear compared to like patients who received only chemotherapy.
A team of University of Houston pharmaceutical researchers is reporting a newly recognized process of drug metabolism in the intestines - followed by recycling through the liver - that could have important implications for developing treatments for intestinal diseases and for taking multiple medications at the same time.
The Yale Global Health Leadership Institute announces a new partnership with Management Science for Health, as part of the United States Agency for International Development (USAID)-funded Leadership, Management and Governance Project.
New study from researchers in Finland and the United Kingdom reveals that tumors lacking a protein called BAP1 have an ineffective immune reaction against cancer, thus rendering immunotherapies ineffectual, particularly in uveal melanomas.
› Verified 2 days ago
David T Dunn, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 Fm 1187 E, Crowley, TX 76036 Phone: 817-568-2023 Fax: 817-568-2738 | |
Sheila K Horsley, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 787 E. Fm 1187, Ste A, Crowley, TX 76036 Phone: 817-293-6988 Fax: 817-293-6729 | |
Dr. Edward L Baker Iii, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 125 South Texas St, Crowley, TX 76036 Phone: 817-297-4309 Fax: 817-297-7183 |